These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20973143)

  • 1. [First experience of using lantox (botulinum toxin A) in chronic pelvic pain syndrome combined with bladder emptying dysfunction].
    Krivoborodov GG; Shumilo DV; Vasil'ev AV
    Urologiia; 2010; (2):60-2. PubMed ID: 20973143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinic toxin type a in combined treatment of males with chronic pelvic pain syndrome in combination with bladder emptying dysfunction].
    Krivoborodov GG; Shumilo DV; Basil'ev AV; Tur EI; Poddubnaia NV
    Urologiia; 2011; (5):67-72. PubMed ID: 22279792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lantox treatment of neurogenic dysfunction of the bladder].
    Maksimov VA; Saliukov RV; Martov AG; Borisik VI; Saliukova IuR
    Urologiia; 2010; (5):53-6. PubMed ID: 21254642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of urethral injection of botulinum A toxin in the treatment of voiding dysfunction after radical hysterectomy.
    Kuo HC
    Urol Int; 2005; 75(3):247-51. PubMed ID: 16215314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity.
    Kuo HC
    Urology; 2003 Mar; 61(3):550-4. PubMed ID: 12639645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction.
    Kuo HC
    J Urol; 2003 Nov; 170(5):1908-12. PubMed ID: 14532805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
    Kuo HC
    Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
    Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
    Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.
    Franco I; Landau-Dyer L; Isom-Batz G; Collett T; Reda EF
    J Urol; 2007 Oct; 178(4 Pt 2):1775-9; discussion 1779-80. PubMed ID: 17707430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinum A toxin in the treatment of patients with detrusor external sphincter dyssynergia and neurogenic low detrusor contractility].
    Mazo EB; Krivoborodov GG; Efremov NS
    Ter Arkh; 2008; 80(10):49-52. PubMed ID: 19105415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum A toxin treatment of urethral sphincter pseudodyssynergia in patients with cerebrovascular accidents or intracranial lesions.
    Chen YH; Kuo HC
    Urol Int; 2004; 73(2):156-61; discussion 161-2. PubMed ID: 15331901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with botulinum toxin in children with chronic anal fissure.
    Husberg B; Malmborg P; Strigård K
    Eur J Pediatr Surg; 2009 Oct; 19(5):290-2. PubMed ID: 19746337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction.
    Schulte-Baukloh H; Weiss C; Stolze T; Stürzebecher B; Knispel HH
    Urology; 2005 Jul; 66(1):82-7. PubMed ID: 15992872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome.
    Gottsch HP; Yang CC; Berger RE
    Scand J Urol Nephrol; 2011 Feb; 45(1):72-6. PubMed ID: 21062115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder.
    Mokhless I; Gaafar S; Fouda K; Shafik M; Assem A
    J Urol; 2006 Oct; 176(4 Pt 2):1767-70; discussion 1770. PubMed ID: 16945643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and durability of botulinum-A toxin for refractory dysfunctional voiding in children.
    Vricella GJ; Campigotto M; Coplen DE; Traxel EJ; Austin PF
    J Urol; 2014 May; 191(5 Suppl):1586-91. PubMed ID: 24679879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Botulinum toxin type A in patients with overactive bladder].
    Krivoborodov GG; Vasil'ev AV; Shumilo DV; Ivanov AV; Tur EI
    Urologiia; 2010; (3):36-40. PubMed ID: 20734876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection of botulinum toxin type A in the urethral sphincter to treat lower urinary tract dysfunction: review of indications, techniques and results: 2011 update.
    Mahfouz W; Karsenty G; Corcos J
    Can J Urol; 2011 Aug; 18(4):5787-95. PubMed ID: 21854710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction.
    Kuo HC
    Urology; 2007 Jan; 69(1):57-61; discussion 61-2. PubMed ID: 17270614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.